InsidersTradesSigma
Browse the detailed record of transactions filed by Dahlbeck Scott, Directeur Médical. Officer active across 1 companies, notably Kiromic Biopharma, Inc.. Cumulatively, 1 disclosures have been published. Regulator: SEC (Form 4). The full history is free.
1 of 1 declaration
Scott Dahlbeck is the Chief Medical Officer at Kiromic Biopharma, Inc. He is responsible for the company's medical strategy and oversees research and development initiatives.